Damage of DNA by environmental carcinogens is assumed to be a principle factor in the induction of mutations and the development of cancer in humans. The p53 tumor suppressor gene is the most frequently mutated gene in human malignancies. One popular hypothesis is that the spectrum of mutations found in different cancers may bear the signature of the mutagenesis process. To test this hypothesis, we will undertake a detailed analysis of the mutagenesis process at the p53 locus using in vitro systems. As a first step in this direction, we will investigate in different cell types the chromatin structure at the critical p53 exons including an analysis of nucleosome association and DNA binding proteins. To understand the mechanisms of mutagenesis, we will analyze DNA damage and DNA repair events at the DNA sequence level in human cells treated with several different mutagens and carcinogens. We will apply the ligation-mediated polymerase chain reaction (LMPCR), a uniquely sensitive technique for in vivo mapping of DNA adducts, to determine the frequency of a number of different mutagenic DNA adducts at each nucleotide position of the p53 gene's exons five through nine. Repair rates for selected DNA adducts will analyzed to determine if repair is sequence-specific. An increased adduct frequency and/or decreased repair rates at specific nucleotide positions may create mutation hot spots. Data from analysis of chromatin structure, sequence-dependent adduct frequency maps, and repair rates will be compared with published frequencies of mutants found in a variety of human cancers including those for with involvement of an environmental carcinogen is suspected . Thus we will attempt to provide in vitro model systems to study the basic molecular mechanism that give rise to mutations in the p53 gene.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Research Program Projects (P01)
Project #
1P01CA069449-01A1
Application #
5209523
Study Section
Project Start
Project End
Budget Start
Budget End
Support Year
1
Fiscal Year
1996
Total Cost
Indirect Cost
Sanders, M H; Bates, S E; Wilbur, B S et al. (2004) Repair rates of R-band, G-band and C-band DNA in murine and human cultured cells. Cytogenet Genome Res 104:35-45
Dai, S M; O'Connor, T R; Holmquist, G P et al. (2002) Ligation-mediated PCR: robotic liquid handling for DNA damage and repair. Biotechniques 33:1090-7
Komura , J; Ikehata, H; Hosoi, Y et al. (2001) Mapping psoralen cross-links at the nucleotide level in mammalian cells: suppression of cross-linking at transcription factor- or nucleosome-binding sites. Biochemistry 40:4096-105
Cloutier, J F; Castonguay, A; O'Connor, T R et al. (2001) Alkylating agent and chromatin structure determine sequence context-dependent formation of alkylpurines. J Mol Biol 306:169-88
Chen, J Z; Smith, L; Pfeifer, G P et al. (2001) Fluorescence-based directed termination PCR: direct mutation characterization without sequencing. Nucleic Acids Res 29:E17
Rodriguez, H; Akman, S A; Holmquist, G P et al. (2000) Mapping oxidative DNA damage using ligation-mediated polymerase chain reaction technology. Methods 22:148-56
Dai, S M; Chen, H H; Chang, C et al. (2000) Ligation-mediated PCR for quantitative in vivo footprinting. Nat Biotechnol 18:1108-11
Miao, F; Bouziane, M; Dammann, R et al. (2000) 3-Methyladenine-DNA glycosylase (MPG protein) interacts with human RAD23 proteins. J Biol Chem 275:28433-8
Bouziane, M; Miao, F; Bates, S E et al. (2000) Promoter structure and cell cycle dependent expression of the human methylpurine-DNA glycosylase gene. Mutat Res 461:15-29
Pfeifer, G P (2000) p53 mutational spectra and the role of methylated CpG sequences. Mutat Res 450:155-66

Showing the most recent 10 out of 33 publications